Get the Stockscreener App
321.49
1.18%
3.74
After Hours:
321.49
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $321.49, with a volume of 3.02M.
It is up +1.18% in the last 24 hours and down -4.98% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$317.75
Open:
$318.21
24h Volume:
3.02M
Relative Volume:
1.33
Market Cap:
$123.25B
Revenue:
$25.27B
Net Income/Loss:
$3.34B
P/E Ratio:
37.24
EPS:
8.6334
Net Cash Flow:
$4.57B
1W Performance:
+6.42%
1M Performance:
-4.98%
6M Performance:
-10.82%
1Y Performance:
-17.47%
1-Day Range:
$313.98
$322.87
1-Week Range:
$298.46
$322.87
52-Week Range:
$281.00
$404.14
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
321.49 | 120.08B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
88.38 | 153.12B | 45.13B | 6.28B | 7.38B | 3.5895 |
MDT
Medtronic Plc
|
78.15 | 99.27B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
56.67 | 83.12B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.97 | 47.44B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Leerink Partners | Outperform |
| Feb-20-26 | Initiated | William Blair | Outperform |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Stryker Corporation (SYK) Announces Leadership Transition in Acc - GuruFocus
Stryker Corp. stock (US8636671013): Growth story continues after strong results - AD HOC NEWS
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker (SYK) appoints Emily Baculik CAO as Berry shifts to advisor - Stock Titan
PNC Financial Services Group Inc. Lowers Stock Position in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Stock Position Increased by Atle Fund Management AB - MarketBeat
Stryker: Investors May Have Overreacted To Q1 Weakness (NYSE:SYK) - Seeking Alpha
Is Wall Street Bullish or Bearish on Stryker Corporation Stock? - Barchart.com
Stryker Corp. stock (US8636671013): growth story continues after strong recent results and M&A move - AD HOC NEWS
Stryker Corp. stock (US8636671013): acquisition news and medical device growth story - AD HOC NEWS
Stryker Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Stryker’s SWOT analysis: medical device stock shows robust growth in robotics - Investing.com
Stryker’s $835 Million AVS Deal Highlights Growing Role of Michigan’s Medtech Development Pipeline - citybiz
Resona Asset Management Co. Ltd. Trims Stock Holdings in Stryker Corporation $SYK - MarketBeat
Michigan medtech startup draws $835M Stryker buyout deal - Stock Titan
Stryker Corporation $SYK Shares Bought by AMF Tjanstepension AB - MarketBeat
Stericycle stock (US8636671013): turnaround story gains focus after latest earnings and outlook upda - AD HOC NEWS
Stryker Corp. stock (US8636671013): earnings momentum and hospital demand keep medical device giant - AD HOC NEWS
Stryker Corp (NYSE:SYK) Passes the Caviar Cruise Quality Screen - ChartMill
Stryker Corp. stock (US8636671013): quarterly results keep medical device demand in focus - AD HOC NEWS
Stryker stock (US8636671013): Results and product momentum remain in focus - AD HOC NEWS
Stericycle stock (US8636671013): restructuring progress and earnings in focus - AD HOC NEWS
Thrivent Financial for Lutherans Increases Position in Stryker Corporation $SYK - MarketBeat
Dana Investment Advisors Inc. Sells 6,037 Shares of Stryker Corporation $SYK - MarketBeat
Stryker restores most manufacturing after hack damaged networks - MSN
Stryker Corp. Hits New 52-Week Low at USD 284.98 - Markets Mojo
Is There Now An Opportunity In Stryker (SYK) After Recent Share Price Pullback - Yahoo Finance
The Robotic Spine Institute of Las Vegas Announces Dr. Kornelis Poelstra’s Completion of 2,000 Robotic Spine Surgeries - GlobeNewswire Inc.
Stryker stock (US8636671013): Medical-device demand stays in focus after fresh company news - AD HOC NEWS
Stryker Corp. stock (US8636671013): Analyst target cut meets upbeat Wall Street outlook - AD HOC NEWS
Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom - 24/7 Wall St.
Is Stryker Corporation (SYK) Under Pressure? Truist Lowers Outlook but Keeps Hold Rating - Insider Monkey
Michigan fund lands 30x return as Stryker buys UM spinout for up to $835M - Crain's Grand Rapids Business
BofA Securities Maintains Stryker Corp(SYK.US) With Buy Rating - Moomoo
Stryker’s Kevin Lobo remains highest paid CEO in West Michigan - Crain's Grand Rapids Business
Stryker Corp stock (US8636671013): Medical technology leader with strong US market presence - AD HOC NEWS
Vision Retirement, LLC's Stryker Corp(SYK) Holding History - GuruFocus
Stryker Corp at Bank of America Global Healthcare Conference Transcript - GuruFocus
Stryker Corp Stock (SYK) Moved Up by 3.02% on May 13: Drivers Behind the Movement - TradingKey
Earnings Miss: Stryker Corporation Missed EPS By 15% And Analysts Are Revising Their Forecasts - Yahoo Finance
Stryker Corp stock (US8636671013): Shares rise 3.5% on vascular M&A momentum - AD HOC NEWS
Rothschild & Redburn Co Adjusts Price Target on Stryker to $346 From $420, Maintains Neutral Rating - Moomoo
Stryker Corp stock (US8636671013): HR chief's recent share sales - AD HOC NEWS
Stryker and Max Smart Hospital, Saket Partner to Advance Surgeon Training and Education in Robotic-Arm Assisted Joint Replacement - Yahoo Finance
Stryker Corporation: Shareholders Board Members Managers and Company Profile | CA8636701051 - marketscreener.com
Argus cuts Stryker stock price target on cyberattack impact - Investing.com India
Stryker Corp (SYK) Shares Surge 3.1% -- What GF Score of 92 Tells Investors - GuruFocus
[Form 4] STRYKER CORP Insider Trading Activity - Stock Titan
Stryker VP, chief HR officer M Kathryn Fink sells $2.47m in stock By Investing.com - Investing.com South Africa
Stryker VP, chief HR officer M Kathryn Fink sells $2.47m in stock - Investing.com Canada
List of 55 Acquisitions by Stryker (May 2026) - Tracxn
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):